Experimental Therapeutic Strategies for Severe Sepsis

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Annals of the New York Academy of Sciences

• Publication date

  2008-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1196/annals.1418.011PMID 19076379
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• T-cell regulation: with complements from innate immunity

  2007cited by this paper
• High-mobility group box-1 isoforms as potential therapeutic targets in sepsis.

  2007cited by this paper
• Potential antiinflammatory role of insulin via the preferential polarization of effector T cells toward a T helper 2 phenotype.

  2007cited by this paper
• Selective &agr;7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis*

  2007cited by this paper
• Ethyl pyruvate: a novel anti‐inflammatory agent

  2007cited by this paper
• Current controversy related to glucocorticoid and insulin therapy in the intensive care unit.

  2007cited by this paper
• The grateful dead: damage‐associated molecular pattern molecules and reduction/oxidation regulate immunity

  2007cited by this paper
• Endotoxemia and sepsis mortality reduction by non-anticoagulant–activated protein C

  2007cited by this paper
• Role of HMGB1 in apoptosis-mediated sepsis lethality.

  2006cited by this paper
• Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis

  2006cited by this paper
• Role of HMGB1 in apoptosis-mediated sepsis lethality

  2006cited by this paper
• Hyperglycemia in the critically ill patient.

  2006cited by this paper
• Intensive insulin therapy in the medical ICU.

  2006cited by this paper
• Insulin reduces the multiple organ injury and dysfunction caused by coadministration of lipopolysaccharide and peptidoglycan independently of blood glucose: Role of glycogen synthase kinase-3&bgr; inhibition*

  2006cited by this paper
• Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia.

  2006cited by this paper
• Management of sepsis.

  2006cited by this paper
• The Role of Complement, C5a and Its Receptors in Sepsis and Multiorgan Dysfunction Syndrome

  2006cited by this paper
• Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein

  2006cited by this paper
• Molecular dynamics simulations of interaction between protein-tyrosine phosphatase 1B and a bidentate inhibitor

  2006cited by this paper
• HMGB-1 AS A THERAPEUTIC TARGET FOR INFECTIOUS AND INFLAMMATORY DISORDERS

  2006cited by this paper
• The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice.

  2006cited by this paper
• The complement component C5a induces the expression of plasminogen activator inhibitor‐1 in human macrophages via NF‐κB activation

  2006cited by this paper
• Novel therapies for sepsis: a review.

  2005cited by this paper
• The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion

  2005cited by this paper
• HMGB1 contributes to the development of acute lung injury after hemorrhage.

  2005cited by this paper
• The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis.

  2005cited by this paper
• New Glucocorticoids on the Horizon: Repress, Don't Activate!

  2005cited by this paper
• Glycemic and nonglycemic effects of insulin: how do they contribute to a better outcome of critical illness?

  2005cited by this paper
• Metabolic Cardioprotection by Pyruvate: Recent Progress

  2005cited by this paper
• NF-kappaB: linking inflammation and immunity to cancer development and progression.

  2005cited by this paper
• The role of HMGB-1 on the development of necrosis during hepatic ischemia and hepatic ischemia/reperfusion injury in mice.

  2005cited by this paper
• Suppression of HMGB1 release by stearoyl lysophosphatidylcholine:an additional mechanism for its therapeutic effects in experimental sepsis.

  2005cited by this paper
• Autonomic neural regulation of immunity

  2005cited by this paper
• The "cytokine profile": a code for sepsis.

  2005cited by this paper
• The role of CXCR2/CXCR2 ligands in acute lung injury.

  2005cited by this paper
• Insulin prevents liver damage and preserves liver function in lipopolysaccharide-induced endotoxemic rats.

  2005cited by this paper
• High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

  2005cited by this paper
• NF-κB: linking inflammation and immunity to cancer development and progression

  2005cited by this paper
• Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: A possible explanation of reduced morbidity and mortality?*

  2005cited by this paper
• Ethyl Pyruvate Ameliorates Liver Ischemia-Reperfusion Injury by Decreasing Hepatic Necrosis and Apoptosis

  2005cited by this paper
• Glucocorticoids and sepsis.

  2005cited by this paper
• New glucocorticoids on the horizon: repress, don't activate!

  2005cited by this paper
• Alpha-chemokine receptor blockade reduces high mobility group box 1 protein-induced lung inflammation and injury and improves survival in sepsis.

  2005cited by this paper
• ISO-1 Binding to the Tautomerase Active Site of MIF Inhibits Its Pro-inflammatory Activity and Increases Survival in Severe Sepsis*

  2005cited by this paper
• The vagus nerve and the nicotinic anti-inflammatory pathway

  2005cited by this paper
• Intensive insulin therapy protects the endothelium of critically ill patients.

  2005cited by this paper
• Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation

  2005cited by this paper
• Ethyl Pyruvate Inhibits Nuclear Factor-κB-Dependent Signaling by Directly Targeting p65

  2004cited by this paper
• The action mode of lysophosphatidylcholine in human monocytes.

  2004cited by this paper
• Contributions of high mobility group box protein in experimental and clinical acute lung injury.

  2004cited by this paper
• Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms

  2004cited by this paper
• Mechanisms of glucocorticoid receptor signaling during inflammation.

  2004cited by this paper
• Insulin Treatment Improves the Systemic Inflammatory Reaction to Severe Trauma

  2004cited by this paper
• Human genetics: An inflammatory issue

  2004cited by this paper
• Bench-to-bedside review: Understanding genetic predisposition to sepsis

  2004cited by this paper
• Acute Hyperinsulinemia Restrains Endotoxin-induced Systemic Inflammatory Response: An Experimental Study in a Porcine Model

  2004cited by this paper
• The dark side of C5a in sepsis

  2004cited by this paper
• Overview of the Actions of Glucocorticoids on the Immune Response: A Good Model to Characterize New Pathways of Immunosuppression for New Treatment Strategies

  2004cited by this paper
• Nicotine attenuates oxidative stress, activation of redox-regulated transcription factors and induction of proinflammatory genes in compressive spinal cord trauma.

  2004cited by this paper
• Insulin Treatment Improves Hepatic Morphology and Function Through Modulation of Hepatic Signals After Severe Trauma

  2004cited by this paper
• Relationship of early hyperglycemia to mortality in trauma patients.

  2004cited by this paper
• Importance of hemostatic gene polymorphisms for susceptibility to and outcome of severe sepsis

  2004cited by this paper
• Lysophosphatidylcholine Enhances Cytokine Production of Endothelial Cells via Induction of L-Type Amino Acid Transporter 1 and Cell Surface Antigen 4F2

  2004cited by this paper
• Insulin attenuates the systemic inflammatory response in endotoxemic rats.

  2004cited by this paper
• Evidence That Glutathione Depletion Is a Mechanism Responsible for the Anti-Inflammatory Effects of Ethyl Pyruvate in Cultured Lipopolysaccharide-Stimulated RAW 264.7 Cells

  2004cited by this paper
• Lysophosphatidylcholine Enhances Cytokine Production of Endothelial Cells via Induction of L-Type Amino Acid Transporter 1 and Cell Surface Antigen 4F2

  2004cited by this paper
• Antioxidant properties of N‐acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease

  2004cited by this paper
• Adrenocorticotropin reverses hemorrhagic shock in anesthetized rats through the rapid activation of a vagal anti-inflammatory pathway.

  2004cited by this paper
• Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis

  2004cited by this paper
• Ethyl pyruvate: a novel treatment for sepsis and shock.

  2004cited by this paper
• How does blood glucose control with insulin save lives in intensive care?

  2004cited by this paper
• Recombinant HMGB1 with cytokine-stimulating activity.

  2004cited by this paper
• Regulation of monocyte migration by amphoterin (HMGB1).

  2004cited by this paper
• Involvement of Toll-like Receptors 2 and 4 in Cellular Activation by High Mobility Group Box 1 Protein*

  2004cited by this paper
• Therapeutic effects of lysophosphatidylcholine in experimental sepsis

  2004cited by this paper
• Sensing Environmental Lipids by Dendritic Cell Modulates Its Function 1

  2004cited by this paper
• Ethyl pyruvate ameliorates distant organ injury in a murine model of acute necrotizing pancreatitis*

  2004cited by this paper
• Can nicotine treat sepsis?

  2004cited by this paper
• Extracellular role of HMGB1 in inflammation and sepsis

  2004cited by this paper
• Corticosteroids for treating severe sepsis and septic shock.

  2004cited by this paper
• Glucocorticoid regulation of the inflammatory response to injury

  2004cited by this paper
• Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation

  2004cited by this paper
• HMGB1 is an endogenous immune adjuvant released by necrotic cells

  2004cited by this paper
• Lysophosphatidylcholine is a regulator of tyrosine kinase activity and intracellular Ca(2+) level in Jurkat T cell line.

  2004cited by this paper
• Metabolism and biochemical effects of nicotine for primary care providers.

  2004cited by this paper
• Transdermal nicotine for induction of remission in ulcerative colitis.

  2004cited by this paper
• Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock

  2004cited by this paper
• Ethyl Pyruvate Ameliorates Intestinal Epithelial Barrier Dysfunction in Endotoxemic Mice and Immunostimulated Caco-2 Enterocytic Monolayers

  2003cited by this paper
• Cytokine-mediated inflammation in acute lung injury.

  2003cited by this paper
• Ethyl pyruvate: a novel anti-inflammatory agent.

  2003cited by this paper
• Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice.

  2003cited by this paper
• Complement C5a in the sepsis syndrome--too much of a good thing?

  2003cited by this paper
• Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels.

  2003cited by this paper
• The epidemiology of sepsis in the United States from 1979 through 2000.

  2003cited by this paper
• Regulation by C5a of neutrophil activation during sepsis.

  2003cited by this paper
• Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes.

  2003cited by this paper
• Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells.

  2003cited by this paper
• Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion

  2003cited by this paper
• Ethyl Pyruvate Provides Durable Protection Against Inflammation-Induced Intestinal Epithelial Barrier Dysfunction

  2003cited by this paper
• Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

  2003cited by this paper

• The Function of Microglia in Cognitive Impairment Influenced by Sleep Deprivation

  2026cites this paper
• Association between serum uric acid to albumin ratio and all-cause mortality in critically ill patients with sepsis: a retrospective study

  2025cites this paper
• The Intersection of Trauma and Immunity: Immune Dysfunction Following Hemorrhage

  2024cites this paper
• Elevated serum albumin-to-creatinine ratio as a protective factor on clinical outcomes among critically ill patients with sepsis: a retrospective study

  2024cites this paper
• Two flavonoids, baicalein and naringin, are effective as anti-inflammatory and anti-oxidant agents in a rat model of polymicrobial sepsis

  2023cites this paper
• Prognostic impact of blood urea nitrogen to albumin ratio on patients with sepsis: a retrospective cohort study

  2023cites this paper
• Prognostic impact of blood urea nitrogen to albumin ratio on patients with sepsis: A retrospective cohort study

  2022cites this paper
• Aerobic exercise training engages cholinergic signaling to improve emphysema induced by cigarette smoke exposure in mice.

  2022cites this paper
• Refining the Pediatric Multiple Organ Dysfunction Syndrome.

  2022cites this paper
• Nicotinic Acetylcholine Receptor Involvement in Inflammatory Bowel Disease and Interactions with Gut Microbiota

  2021cites this paper
• Detection of Early Cytokine Storm in Patients with Septic Shock After Abdominal Surgery

  2020cites this paper
• Role of C-Reactive Protein (CRP) in Sepsis: Severity and Outcome

  2020cites this paper
• Nicotinic Mitigation of Neuroinflammation and Oxidative Stress After Chronic Sleep Deprivation

  2019cites this paper
• A nomogram for predicting the risk of sepsis in patients with acute cholangitis

  2019cites this paper
• Upregulation of microRNA‐351 exerts protective effects during sepsis by ameliorating skeletal muscle wasting through the Tead‐4‐mediated blockade of the Hippo signaling pathway

  2018cites this paper
• Patterns of Death in Patients with Sepsis and the Use of Hydrocortisone, Ascorbic Acid, and Thiamine to Prevent These Deaths

  2018cites this paper
• Pathophysiology of systemic inflammatory response syndrome and multiorgan dysfunction syndrome in acute pancreatitis

  2017cites this paper
• Sepsis: Current Definition, Pathophysiology, Diagnosis, and Management

  2017cites this paper
• Immunotherapeutic implications of IL-6 blockade for cytokine storm.

  2016cites this paper
• Anti-oxidant and anti-inflammatory effects of apigenin in a rat model of sepsis: an immunological, biochemical, and histopathological study

  2016cites this paper
• Effects of choline treatment in concentrations of serum matrix metalloproteinases (MMPs), MMP tissue inhibitors (TIMPs) and immunoglobulins in an experimental model of canine sepsis.

  2016cites this paper
• Kukoamine B promotes TLR4-independent lipopolysaccharide uptake in murine hepatocytes

  2016cites this paper
• Gemfibrozil attenuates the inflammatory response and protects rats from abdominal sepsis

  2015cites this paper
• Pulmonary Inflammation Is Regulated by the Levels of the Vesicular Acetylcholine Transporter

  2015cites this paper
• Anti-inflammatory role of microglial alpha7 nAChRs and its role in neuroprotection.

  2015cites this paper
• Zinc Regulates the Acute Phase Response and Serum Amyloid A Production in Response to Sepsis through JAK-STAT3 Signaling

  2014cites this paper
• Early management of severe sepsis: concepts and controversies.

  2014cites this paper
• Recent Advances in the Molecular Characterization of Circulating Tumor Cells

  2014cites this paper
• Acoustophoretic sample preparation for PCR in sepsis diagnostics

  2013cites this paper
• Interferon regulatory factor-1 mediates the release of high mobility group box-1 in endotoxemia in mice.

  2013cites this paper
• Cytokines in Sepsis: Potent Immunoregulators and Potential Therapeutic Targets—An Updated View

  2013cites this paper
• BTZO-2, an antioxidant response element-activator, provides protection against lethal endotoxic shock in mice.

  2013cites this paper
• The Role of α7 Nicotinic Acetylcholine Receptors in the Pharmacotherapy of Neurodegenerative Diseases

  2013cites this paper
• Continuous Administration of Enteral Lipid- and Protein-Rich Nutrition Limits Inflammation in a Human Endotoxemia Model

  2013cites this paper
• NOS2 Induction and HO-1-Mediated Transcriptional Control in Gram-Negative Peritonitis

  2013cites this paper
• Comparison of reducing effect on lung injury of dexamethasone and bosentan in acute lung injury: an experimental study

  2013cites this paper
• Recombinant production of the human complement factor 5a in Escherichia coli

  2013cites this paper
• Alternate day calorie restriction improves systemic inflammation in a mouse model of sepsis induced by cecal ligation and puncture.

  2012cites this paper
• Anti-Inflammatory Role of Natural Polyphenols and Their Degradation Products

  2012cites this paper
• Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients.

  2012cites this paper
• Neostigmine modulates tularemia progression in BALB/c mice

  2012cites this paper
• [A role of alpha-7 nicotinic acetylcholine receptors in pharmacotherapy of neurodegenerative diseases].

  2012cites this paper
• Early release of macrophage migration inhibitory factor after liver ischemia and reperfusion injury in rats.

  2012cites this paper
• Alpha7 Nicotinic Acetylcholine Receptor Is a Target in Pharmacology and Toxicology

  2012cites this paper
• Expression and Subcellular Targeting of Human Complement Factor C5a in Nicotiana species

  2012cites this paper
• Antisense inhibition of secretory and cytosolic phospholipase A2 reduces the mortality in rats with sepsis*

  2012cites this paper
• Dual targets guided screening and isolation of Kukoamine B as a novel natural anti-sepsis agent from traditional Chinese herb Cortex lycii.

  2011cites this paper
• “Merinoff Symposium 2010: Sepsis”—Speaking with One Voice

  2011cites this paper
• Evidence based evaluation of immuno-coagulatory interventions in critical care.

  2011cites this paper
• Kukoamine B, a novel dual inhibitor of LPS and CpG DNA, is a potential candidate for sepsis treatment

  2011cites this paper
• MIF as a disease target: ISO-1 as a proof-of-concept therapeutic.

  2011cites this paper
• Immunomodulation in sepsis: state of the art and future perspective.

  2011cites this paper
• Combination of Imipenem and TAK-242, a Toll-Like Receptor 4 Signal Transduction Inhibitor, Improves Survival in a Murine Model of Polymicrobial Sepsis

  2011cites this paper
• Sildenafil treatment attenuates lung and kidney injury due to overproduction of oxidant activity in a rat model of sepsis: a biochemical and histopathological study

  2011cites this paper
• Neisseria meningitidis and Escherichia coli are protected from leukocyte phagocytosis by binding to erythrocyte complement receptor 1 in human blood.

  2011cites this paper
• Advances in the management of sepsis and the understanding of key immunologic defects.

  2011cites this paper
• Human recombinant activated protein C for severe sepsis.

  2011cites this paper
• Meningococcal sepsis: : Beneficial and harmful inflammatory mechanisms

  2011cites this paper
• Composition alimentaire pour une alimentation par tube intra-opératoire

  2011cites this paper
• Human recombinant activated protein C for severe sepsis.

  2011cites this paper
• CHAPTER 38 – Sepsis

  2010cites this paper
• 'Super high-flux' or 'high cut-off' hemofiltration and hemodialysis.

  2010cites this paper
• IMMUNOMODULATORY PROPERTIES OF PENTOXIFYLLINE ARE MEDIATED VIA ADENOSINE-DEPENDENT PATHWAYS

  2010cites this paper
• Effects of enrofloxacin, flunixin meglumine and dexamethasone on disseminated intravascular coagulation, cytokine levels and adenosine deaminase activity in endotoxaemia in rats.

  2010cites this paper
• Melanocortins and the cholinergic anti-inflammatory pathway.

  2010cites this paper
• Differential effects of glucocorticoids in the establishment and maintenance of endotoxin tolerance

  2010cites this paper
• Postoperative hyperglycemia and surgical site infection in general surgery patients.

  2010cites this paper
• Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function

  2010cites this paper
• Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality

  2010cites this paper
• Lipid-enriched enteral nutrition controls the inflammatory response in murine Gram-negative sepsis

  2010cites this paper
• DAMPening Inflammation by Modulating TLR Signalling

  2010cites this paper
• Merinoff Symposium 2010: Sepsis—An International Call to Action

  2010cites this paper
• Thioredoxin in sepsis: Just another biomarker or a plausible therapeutic target?

  2009cites this paper